18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
about
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?
P2860
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@ast
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@en
type
label
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@ast
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@en
prefLabel
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@ast
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@en
P2093
P2860
P1476
18F-FDG PET/CT of Non-Small Ce ...... cting Histopathologic Response
@en
P2093
Alessandra Curioni
Alex Soltermann
Irene A Burger
Lars Husmann
Martin W Huellner
Paul Stolzmann
Ruben Casanova
Seraina Steiger
Sven Hillinger
P2860
P304
P356
10.2967/JNUMED.115.167684
P407
P577
2016-01-28T00:00:00Z